JANENE LEVY-STILL: Open Payments
NPI 1124423090 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$917 in 23 payments from 7 companies in 2025. Trend: 2023 $259 · 2024 $339 · 2025 $917
Food & beverage: $917
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 11 | $365 |
| ABBVIE INC. | 3 | $192 |
| Alkermes, Inc. | 4 | $185 |
| Vanda Pharmaceuticals Inc. | 2 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: SUBLOCADE, VRAYLAR, LYBALVI, FANAPT, ARISTADA, CAPLYTA, REXULTI, HETLIOZ.
Industry payments across MD — which companies pay providers there.
